{"ORPHApacket":[{"ORPHApacketID":"1914","date":"2019-12-06 00:22:41","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"1914","Name":[{"lang":"en","label":"Vitamin K antagonist embryofetopathy"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_1914","DisorderType":[{"Name":[{"lang":"en","label":"Malformation syndrome"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377789"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Teratogenic Pierre Robin syndrome"}],"ORPHA":"138059","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_138059"},{"Name":[{"lang":"en","label":"Toxic or drug-related embryofetopathy"}],"ORPHA":"251529","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_251529"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Vitamin K antagonist embryofetopathy is characterized by a group of symptoms that may be observed in a fetus or newborn when the mother has taken oral vitamin K antagonists, such as warfarin during pregnancy. Vitamin K antagonists are anticoagulant drugs that provide efficient thromboprophylaxis and that can cross the placenta. 5-12 % of infants exposed to warfarin between 6-9 weeks gestation present nasal hypoplasia and skeletal abnormalities, including short limbs and digits (brachydactyly), and stippled epiphyses. Warfarin fetopathy with central nervous system abnormalities (hydrocephalus, intellectual disability, spasticity, and hypotonia) or ocular abnormalities (microphthalmia, cataract, optic atrophy), fetal loss, and stillbirth, occurs in infants exposed at later gestations. Additional features that have been reported after in utero warfarin exposure include facial dysmorphism (cleft lip and\/or palate, malformed ears), choanal atresia or stenosis, aorta coarctation, situs inversus totalis, bilobed lungs, and ventral midline dysplasia."}],"AverageAgeOfOnsetList":[{"count":"2","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Antenatal"}]},{"Name":[{"lang":"en","label":"Neonatal"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Not applicable"}]}]}],"SynonymList":[{"count":"4","Synonym":[{"lang":"en","label":"Vitamin K antagonist embryopathy"},{"lang":"en","label":"Warfarin embryofetopathy"},{"lang":"en","label":"Warfarin embryopathy"},{"lang":"en","label":"di Sala syndrome"}]}],"HPODisorderAssociationList":[{"count":"26","HPODisorderAssociation":[{"HPOId":"HP:0000158","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000158","HPOTerm":"Macroglossia","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0000238","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000238","HPOTerm":"Hydrocephalus","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0000316","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000316","HPOTerm":"Hypertelorism","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0000365","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000365","HPOTerm":"Hearing impairment","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0000453","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000453","HPOTerm":"Choanal atresia","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0000463","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000463","HPOTerm":"Anteverted nares","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0000470","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000470","HPOTerm":"Short neck","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0000505","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000505","HPOTerm":"Visual impairment","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0000518","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000518","HPOTerm":"Cataract","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0000520","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000520","HPOTerm":"Proptosis","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0000648","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000648","HPOTerm":"Optic atrophy","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0001156","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001156","HPOTerm":"Brachydactyly","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0001249","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001249","HPOTerm":"Intellectual disability","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0001250","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001250","HPOTerm":"Seizures","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0001252","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001252","HPOTerm":"Muscular hypotonia","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0001511","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001511","HPOTerm":"Intrauterine growth retardation","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0002093","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002093","HPOTerm":"Respiratory insufficiency","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0002475","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002475","HPOTerm":"Myelomeningocele","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0002564","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002564","HPOTerm":"Malformation of the heart and great vessels","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0003196","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0003196","HPOTerm":"Short nose","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0005280","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0005280","HPOTerm":"Depressed nasal bridge","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0008056","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0008056","HPOTerm":"Aplasia\/Hypoplasia affecting the eye","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0008420","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0008420","HPOTerm":"Punctate vertebral calcifications","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0008551","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0008551","HPOTerm":"Microtia","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0009882","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0009882","HPOTerm":"Short distal phalanx of finger","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0010655","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0010655","HPOTerm":"Epiphyseal stippling","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]}]}],"HPODisorderSetStatus":[{"ValidationStatus":"y"}]}]}